BLOOD COMPATIBILITY OF 2 DIFFERENT TYPES OF MEMBRANE-OXYGENATOR DURING CARDIOPULMONARY BYPASS IN INFANTS

被引:9
作者
GU, YJ [1 ]
BOONSTRA, PW [1 ]
AKKERMAN, C [1 ]
MUNGROOP, H [1 ]
TIGCHELAAR, I [1 ]
VANOEVEREN, W [1 ]
机构
[1] UNIV GRONINGEN HOSP,DEPT CARDIOTHORAC SURG,BLOOD INTERACT RES LAB,9713 EZ GRONINGEN,NETHERLANDS
关键词
BLOOD COMPATIBILITY; COMPLEMENT; OXYGENATOR; PEDIATRIC; CARDIOPULMONARY BYPASS;
D O I
10.1177/039139889401701006
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The contact of blood with the artificial extracorporeal circuit causes a systemic inflammatory response due to blood activation. In this study, we compared two different paediatric membrane oxygenators used for extracorporeal circulation: a hollow fibre membrane oxygenator (Dideco Masterflo D-701, n=10), and a flat sheet silicone membrane oxygenator (Avecor Kolobow 800-2A, n=10). Blood compatibility was indicated by measuring complement activation as well as leukocyte and platelet activation. In patients perfused with a flat sheet membrane oxygenator, concentrations of complement split products C3a were significantly increased 30 minutes after the start of bypass (p<0.01), whereas only a mild increase of C3a was found in patients perfused with a hollow fibre membrane oxygenator. Leukocyte and platelet counts dropped uniformly in both groups after the start of bypass mainly due to hemodilution. Activation of leukocytes and platelets identified by both plasma beta-glucuronidase and beta-thromboglobulin was similar in both groups. infants perfused with a flat sheet membrane oxygenator received significantly more donor blood than those perfused with a hollow fibre oxygenator (p<0.05). These results indicate that when used during paediatric cardiopulmonary bypass, a flat sheet membrane oxygenator has a higher complement activity than a hollow fibre membrane oxygenator which is probably due to the relatively larger blood-surface contacting area of the oxygenator.
引用
收藏
页码:543 / 548
页数:6
相关论文
共 16 条
[1]  
CAVAROCCHI NC, 1986, J THORAC CARDIOV SUR, V91, P252
[2]  
DELAVAL ME, 1975, J THORAC CARDIOVASC, V69, P144
[3]   LEUKOCYTE ACTIVATION WITH INCREASED EXPRESSION OF CR3 RECEPTORS DURING CARDIOPULMONARY BYPASS [J].
GU, YJ ;
VANOEVEREN, W ;
BOONSTRA, PW ;
DEHAAN, J ;
WILDEVUUR, CRH .
ANNALS OF THORACIC SURGERY, 1992, 53 (05) :839-843
[4]   HEPARIN-COATED CIRCUITS REDUCE THE INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS [J].
GU, YJ ;
VANOEVEREN, W ;
AKKERMAN, C ;
BOONSTRA, PW ;
HUYZEN, RJ ;
WILDEVUUR, CRH .
ANNALS OF THORACIC SURGERY, 1993, 55 (04) :917-922
[5]   FUNCTION OF HUMAN PLATELETS DURING EXTRACORPOREAL-CIRCULATION [J].
HENNESSY, VL ;
HICKS, RE ;
NIEWIAROWSKI, S ;
EDMUNDS, LH ;
COLMAN, RW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 232 (06) :H622-H628
[6]  
HOPE AF, 1981, J THORAC CARDIOV SUR, V81, P880
[7]  
HOWARD RJ, 1988, ARCH SURG-CHICAGO, V123, P1496
[9]  
KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
[10]   THE EFFECTS OF COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS - ATTENUATION BY HYPOTHERMIA, HEPARIN, AND HEMODILUTION [J].
MOORE, FD ;
WARNER, KG ;
ASSOUSA, S ;
VALERI, CR ;
KHURI, SF .
ANNALS OF SURGERY, 1988, 208 (01) :95-103